Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Orderbuch | Analysen | |||||
Historisch | Ausblick |
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 84.88 |
EXOR NV | 15.00 |
Exor NV (Private Equity) | 15.00 |
Artisan Partners LP | 4.89 |
Artisan International Value Fund | 3.82 |
UBS Asset Management (UK) Ltd. | 3.15 |
Government Pension Fund - Global (The) | 2.50 |
Wellington Management Co. LLP | 2.15 |
Amundi Asset Management SA (Investment Management) | 1.43 |
Vanguard Total International Stock Index Fund | 1.35 |
BlackRock Equity Dividend Fund | 1.10 |
Vanguard Health Care Fund | 1.09 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 77'400 | 80'495 | 81'592 | 78'189 | 77'233 |
Umsatz pro Mitarbeiter in Mio. EUR | 0.23 | 0.24 | 0.24 | 0.22 | 0.23 |
Bilanz (in Mio. EUR) - Aktiva
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 9'572 | 9'459 | 11'227 | 10'348 | 10'259 |
Summe Anlagevermögen | 16'909 | 18'044 | 18'804 | 21'417 | 21'449 |
Summe Aktiva | 26'019 | 27'016 | 27'925 | 31'172 | 30'963 |
Bilanz (in Mio. EUR) - Passiva
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 4'821 | 5'447 | 6'934 | 6'979 | 8'201 |
Summe Fremdkapital | 13'902 | 14'391 | 16'024 | 16'698 | 17'681 |
Summe Eigenkapital | 12'117 | 12'625 | 11'901 | 14'474 | 13'282 |
Summe Passiva | 26'019 | 27'016 | 27'925 | 31'172 | 30'963 |
Adresse
Philips Center, 1096 BC Amsterdam | |
Telefon | +31 (20) 597-77-77 |
URL | http://www.philips.com |
Management
A. Marc Harrison
Member-Supervisory Board |
Abhijit Bhattacharya
Chief Financial Officer & Executive Vice President |
Andy Ho
CEO-Philips Greater China & Executive VP |
Bert van Meurs
Chief Business Leader-Image Guided Therapy & EVP |
David E. I. Pyott
Member-Supervisory Board |
Deeptha Khanna
EVP & Chief Business Leader- Personal Health |
Derya Guzel
Manager-Investor Relations |
Edwin Paalvast
Executive Vice President |
Feike Sijbesma
Chairman-Supervisory Board |
Heidi Sichien
Chief People Officer |
Hendrica W. P. M. A. Verhagen
Member-Supervisory Board |
Indra Krishnamurthy Nooyi
Member-Supervisory Board |
Jako Eleveld
Head-IP Licensing & Vice President |
Jan Kimpen
Chief Medical Officer |
Jeff DiLullo
Chief Market Leader-Philips North America |
Julia M. Strandberg
EVP & Chief Business Leader-Connected Care |
Karen Lykke Sörensen
Chief Executive Officer-Nordic Region |
Marnix van Ginneken
Chief Legal Officer & Executive Vice President |
Mary Elizabeth Doherty
Member-Supervisory Board |
Nathalie Lam
Global Head-Sponsorship & Lead Inclusion |
Nico Jonkers
Global Head-Innovation Personal Health |
Paulus Stoffels
Vice Chairman-Supervisory Board & Secretary |
Peter D. Löscher
Member-Supervisory Board |
Roy Jakobs
President & Chief Executive Officer |
Sanjay J. Poonen
Member-Supervisory Board |
Sean Carney
Chief Design Officer |
Shez Partovi
Chief Innovation & Strategy Officer |
Sock Koong Chua
Member-Supervisory Board |
Steve C. de Baca
Chief Patient Safety & Quality Officer |
Willem T. Appelo
Chief Operating Officer |